Penumbra Cash Flow from Operating Activities 2014-2025 | PEN
Penumbra annual/quarterly cash flow from operating activities history and growth rate from 2014 to 2025. Cash flow from operating activities can be defined as a company's cash flows from operations.
- Penumbra cash flow from operating activities for the quarter ending March 31, 2025 was $0.049B, a 27.88% increase year-over-year.
- Penumbra cash flow from operating activities for the twelve months ending March 31, 2025 was $0.396B, a 74.39% increase year-over-year.
- Penumbra annual cash flow from operating activities for 2024 was $0.168B, a 73.1% increase from 2023.
- Penumbra annual cash flow from operating activities for 2023 was $0.097B, a 274.87% decline from 2022.
- Penumbra annual cash flow from operating activities for 2022 was $-0.056B, a 685.78% decline from 2021.
| Penumbra Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2024 | $168 |
| 2023 | $97 |
| 2022 | $-56 |
| 2021 | $10 |
| 2020 | $-33 |
| 2019 | $27 |
| 2018 | $29 |
| 2017 | $13 |
| 2016 | $-13 |
| 2015 | $-21 |
| 2014 | $-6 |
| 2013 | $-3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $11.352B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $190.614B | 83.49 |
| Thermo Fisher Scientific (TMO) | United States | $159.404B | 19.28 |
| Alcon (ALC) | Switzerland | $48.032B | 31.93 |
| Edwards Lifesciences (EW) | United States | $44.155B | 28.89 |
| IDEXX Laboratories (IDXX) | United States | $38.206B | 43.91 |
| DexCom (DXCM) | United States | $31.474B | 48.65 |
| IQVIA Holdings (IQV) | United States | $26.853B | 14.86 |
| Mettler-Toledo (MTD) | United States | $22.677B | 26.97 |
| STERIS (STE) | Ireland | $22.038B | 25.20 |
| Waters (WAT) | United States | $20.727B | 29.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.648B | 0.00 |
| Hologic (HOLX) | United States | $11.751B | 12.77 |
| Sysmex ADR (SSMXY) | Japan | $11.664B | 0.00 |
| Globus Medical (GMED) | United States | $9.697B | 22.45 |
| Masimo (MASI) | United States | $8.800B | 36.93 |
| Teleflex (TFX) | United States | $5.431B | 8.96 |
| Glaukos (GKOS) | United States | $4.963B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.067B | 21.31 |
| TransMedics (TMDX) | United States | $3.119B | 91.30 |
| PROCEPT BioRobotics (PRCT) | United States | $3.010B | 0.00 |
| Veracyte (VCYT) | United States | $2.453B | 44.11 |
| Nihon Kohden (NHNKY) | Japan | $2.160B | 11.81 |
| LivaNova (LIVN) | United Kingdom | $1.978B | 11.97 |
| Elekta AB (EKTAY) | Sweden | $1.956B | 17.59 |
| Alphatec Holdings (ATEC) | United States | $1.751B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.418B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.116B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.026B | 5.49 |
| Artivion (AORT) | United States | $1.015B | 95.08 |
| AxoGen (AXGN) | United States | $0.763B | 0.00 |
| IRadimed (IRMD) | United States | $0.665B | 33.74 |
| Mesa Laboratories (MLAB) | United States | $0.644B | 14.08 |
| SiBone (SIBN) | United States | $0.606B | 0.00 |
| RxSight (RXST) | United States | $0.595B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.561B | 9.03 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.528B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.512B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.506B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.460B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.401B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.388B | 0.00 |
| NeuroPace (NPCE) | United States | $0.378B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.366B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.333B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.330B | 19.63 |
| Semler Scientific (SMLR) | United States | $0.322B | 6.84 |
| Neuronetics (STIM) | United States | $0.296B | 0.00 |
| CVRx (CVRX) | United States | $0.203B | 0.00 |
| 908 Devices (MASS) | United States | $0.193B | 0.00 |
| Inogen (INGN) | United States | $0.187B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.183B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.169B | 0.00 |
| LENSAR (LNSR) | United States | $0.164B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.151B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.147B | 0.00 |
| Accuray (ARAY) | United States | $0.135B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.132B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.114B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.099B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.097B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.087B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.067B | 10.18 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.054B | 0.00 |
| Hyperfine (HYPR) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.050B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.036B | 0.00 | |
| Biosig Technologies (BSGM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.34 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |